REQUEST A DEMO
Total
USD $0.00
Search more companies

Ntc Bioinvest OOO (Нтц Биоинвест ООО) (Russia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Ntc Bioinvest OOO Profile Updated: October 18, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Ntc Bioinvest OOO (Нтц Биоинвест ООО) is based in Russia, with the head office in Moscow. The company operates in the Pharmaceutical Preparation Manufacturing industry. The company was established on November 08, 2005. 8 (2023) employees currently work for Ntc Bioinvest OOO (Нтц Биоинвест ООО). In its most recent financial highlights, the company reported a net sales revenue increase of 22.3% in 2024. During that time, Ntc Bioinvest OOO (Нтц Биоинвест ООО)’s total assets decreased by 9.46%. In 2024, Ntc Bioinvest OOO (Нтц Биоинвест ООО)’s net profit margin increased by 3.62%.

Headquarters
1, 77, 1/101A
Moscow; Moscow; Postal Code: 119234

Contact Details: Purchase the Ntc Bioinvest OOO (Нтц Биоинвест ООО) report to view the information.

Basic Information
Total Employees:
Purchase the Ntc Bioinvest OOO (Нтц Биоинвест ООО) report to view the information.
Registered Capital:
Purchase the Ntc Bioinvest OOO (Нтц Биоинвест ООО) report to view the information.
Financial Auditors:
Purchase the Ntc Bioinvest OOO (Нтц Биоинвест ООО) report to view the information.
Incorporation Date:
November 08, 2005
Key Executives
Purchase this report to view the information.
Deputy director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Ntc Bioinvest OOO (Нтц Биоинвест ООО) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
22.3%
Total operating revenue
22.3%
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
545.38%
Total Assets
-9.46%
Total Equity
120.57%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
3.62%
Return on Equity (ROE)
36.12%
Quick Ratio
-0.13%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?